Vivaldi Biosciences
Chemicals & Related Products · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3185 Rampart Rd # A, Fort Collins, Color...Phone Number
(970) 492-4366Website
www.vivaldibiosciences.comRevenue
<$5 MillionIndustry
About Vivaldi Biosciences
Vivaldi Biosciences specializes in developing nasal-spray, self-adjuvanting vaccines for viral respiratory diseases using their Delta NS1 technology platform. Their product pipeline includes the DeltaFLU, a universal influenza vaccine in Phase 2 clinical development, and Delta-19, a combination vaccine for COVID-19 and influenza. The Delta NS1 vaccines are designed to induce a robust immune response while ensuring safety by being replication-deficient and non-shedding. The company aims to provide broad protection against various strains of influenza and other viral respiratory diseases.Explore more
Vivaldi Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Vivaldi Biosciences
Compare insights from companies similar to Vivaldi Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Vivaldi Biosciences Tech Stack
A closer look at the technologies used by Vivaldi Biosciences
Top Chemicals & Related Products Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vivaldi Biosciences
Sign Up For FreeTo access detailed company insights
Vivaldi Biosciences specializes in developing nasal-spray, self-adjuvanting vaccines for viral respiratory diseases using their Delta NS1 technology platform. Their product pipeline includes the DeltaFLU, a universal influenza vaccine in Phase 2 clinical development, and Delta-19, a combination vaccine for COVID-19 and influenza. The Delta NS1 vacc... Read More
